radotinib
Showing 1 - 4 of 4
Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)
Active, not recruiting
- Chronic Myeloid Leukemia, Chronic Phase
- Radotinib
- Imatinib
-
Beijing, ChinaPeking University People's Hospital(北京大学人民医院)
Jan 3, 2022
Leukemia, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in India, Korea, Republic of, Thailand
Completed
- Leukemia
- +4 more
- Radotinib
-
Mumbai, Maharashtra, India
- +11 more
Aug 27, 2018
Chronic Myeloid Leukemia Trial in Ulsan (Radotinib)
Unknown status
- Chronic Myeloid Leukemia
- Radotinib
-
Ulsan, Korea, Republic ofUlsan University Hospital
May 10, 2016